Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
clinical trials
life sciences
national blog main
san francisco blog main
san francisco top stories
abaloparatide
biotech
boston blog main
boston top stories
cholesterol
data
europe blog main
europe top stories
european commission
fda
inclisiran
ldl
mark timney
mt sinai hospital
national
national top stories
new york
new york blog main
new york top stories
osteoporosis
pcsk9
peter wijngaard
praluent
prashant vaishnava
radius health
regeneron pharmaceuticals
repatha
romosozumab
sanofi
teriparatide
the medicines co.
ucb
What
drug
2
×
medicine
2
×
aces
amgen
amgen’s
announced
approval
big
carries
ceo
cholesterol
developed
europe
european
flexible
heart
inclisiran
key
lowering
marketing
meant
medco
medicines
nasdaq
nod
open
osteoporosis
passed
pricing
raise
risk
taken
test
twice
warning
week
wins
year
Language
unset
Current search:
amgen
×
drug
×
medicine
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
